Cash & equivalents increased 313.4%
Cash & equivalents changed +313.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$1.6M→$6.8M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TGEN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables decreased 36.8%
Trade receivables changed -36.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$6.6M→$4.2M4 prior comparisons
Inventory increased 24.3%
Inventory changed +24.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$9.7M→$12.0M4 prior comparisons
Operating income decreased 52.3%
Operating income changed -52.3% from the comparable as-filed period.
-$1.4M→-$2.2M3 prior comparisons
Operating margin moved 1806 bp lower
Operating margin changed -1806 basis points from the comparable as-filed period.
-19.35%→-37.42%3 prior comparisons
Net income decreased 46.8%
Net income changed -46.8% from the comparable as-filed period.
-$1.5M→-$2.1M3 prior comparisons
Gross margin moved 408 bp higher
Gross margin changed +408 basis points from the comparable as-filed period.
33.76%→37.83%3 prior comparisons
Current liabilities decreased 41.2%
Current liabilities changed -41.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$14.0M→$8.2M4 prior comparisons
Working capital increased 211.8%
Working capital changed +211.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$5.1M→$15.8M4 prior comparisons
Free-cash-flow proxy increased 11.7%
Free-cash-flow proxy changed +11.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
-$2.7M→-$2.4M4 prior comparisons
Current assets increased 26.2%
Current assets changed +26.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$19.0M→$24.0M4 prior comparisons
Revenue decreased 21.2%
Revenue changed -21.2% from the comparable as-filed period.
$7.3M→$5.7M3 prior comparisons
Capital expenditure decreased 49.8%
Capital expenditure changed -49.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$145,969→$73,2694 prior comparisons
Inventory / revenue moved 7663 bp higher
Inventory / revenue changed +7663 basis points from the comparable as-filed period.
132.69%→209.32%3 prior comparisons
Operating cash flow increased 9.6%
Operating cash flow changed +9.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
-$2.6M→-$2.4M4 prior comparisons
Current ratio increased 114.7%
Current ratio changed +114.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
1.36→2.934 prior comparisons
Receivables / revenue moved 1795 bp lower
Receivables / revenue changed -1795 basis points from the comparable as-filed period.
91.03%→73.08%3 prior comparisons
Stock-based compensation increased 27.5%
Stock-based compensation changed +27.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$42,606→$54,3374 prior comparisons
Operating cash-flow margin moved 528 bp lower
Operating cash-flow margin changed -528 basis points from the comparable as-filed period.
-35.67%→-40.96%3 prior comparisons
Free-cash-flow margin moved 456 bp lower
Free-cash-flow margin changed -456 basis points from the comparable as-filed period.
-37.67%→-42.23%3 prior comparisons
Working capital / assets moved 3215 bp higher
Working capital / assets changed +3215 basis points from the comparable as-filed period.
17.89%→50.03%3 prior comparisons
Research & development increased 19.2%
Research & development changed +19.2% from the comparable as-filed period.
$268,724→$320,2243 prior comparisons
Total assets increased 11.5%
Total assets changed +11.5% from the comparable as-filed period.
$28.4M→$31.6M3 prior comparisons
Gross profit decreased 11.7%
Gross profit changed -11.7% from the comparable as-filed period.
$2.5M→$2.2M3 prior comparisons
R&D / revenue moved 189 bp higher
R&D / revenue changed +189 basis points from the comparable as-filed period.
3.68%→5.57%3 prior comparisons
Capex / revenue moved 73 bp lower
Capex / revenue changed -73 basis points from the comparable as-filed period.
2.00%→1.28%3 prior comparisons
Shares outstanding increased 1.7%
Shares outstanding changed +1.7% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
29,690,798→30,187,8228 prior comparisons
SBC / revenue moved 36 bp higher
SBC / revenue changed +36 basis points from the comparable as-filed period.
0.58%→0.95%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.